Cantel Medical (CMN) Tops Q3 EPS by 6c

Cantel Medical (NYSE: CMN) reported Q3 EPS of $0.35, $0.06 better than the analyst estimate of $0.29. Revenue for the quarter came in at $120.06 million versus the consensus estimate of $135.95 million.

For earnings history and earnings-related data on Cantel Medical (CMN) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• Universal Health Services (UHS) Reiterated at Buy by UBS as Talkspace Acquisition Closed
• HawkEye 360 lock-up ends early, shares eligible Sept. 2